Increase/Decrease in Cash: The total change in cash for the company over the given period.
Rallybio Corporation (RLYB) had Increase/Decrease in Cash of $61.48M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$43.66M |
|
-- |
|
-- |
|
$5.65M |
|
$-5.65M |
|
$50.64M |
|
$44.99M |
|
$44.99M |
|
$43.66M |
|
$43.66M |
|
$43.66M |
|
$43.66M |
|
$-5.65M |
|
$-5.66M |
|
5.70M |
|
5.80M |
|
$7.66 |
|
$7.53 |
|
| Balance Sheet Financials | |
$97.25M |
|
-- |
|
$0.81M |
|
$98.06M |
|
$3.57M |
|
-- |
|
-- |
|
$3.57M |
|
$94.50M |
|
$94.50M |
|
$94.50M |
|
5.31M |
|
| Cash Flow Statement Financials | |
$37.94M |
|
$23.40M |
|
$0.13M |
|
$31.37M |
|
$92.85M |
|
|
Increase/Decrease in Cash |
$61.48M |
$1.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
27.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$37.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
46.21% |
|
46.21% |
|
44.53% |
|
46.21% |
|
$17.81 |
|
$6.54 |
|
$6.54 |
|